BCOP Study Tips
BCOP Study Tips
By listener request! What is BCOP, why pursue it, and some simple tips on studying for the exam.
27 Jul 2023
•
13mins
Chemotherapy Sequencing In Colorectal Cancer
Chemotherapy Sequencing In Colorectal Cancer
A Landmark of OncoPharm from 2004: FOLFIRI --> FOLFOX or FOLFOX --> FOLFIRI.Some interesting dosing to discuss in ... Read more
20 Jul 2023
•
13mins
Similar Podcasts
Phase 1 Clinical Trials In Oncology with Dr. Donald Harvey
Phase 1 Clinical Trials In Oncology with Dr. Donald Harvey
We welcome Dr. Donald Harvey to the podcast to discuss Phase 1 clinical trials in oncology. Topics include goals of Pha... Read more
13 Jul 2023
•
39mins
Investigational Drug Services In Oncology with Dr. Jackie Saunders
Investigational Drug Services In Oncology with Dr. Jackie Saunders
We welcome Jacqueline (Jackie) Saunders to the podcast to talk about investigational drug services (IDS) in oncology and... Read more
6 Jul 2023
•
29mins
NADIM II & Favorable Risk RCC
NADIM II & Favorable Risk RCC
This episode...More evidence to support the use of neoadjuvant ICI/chemo in stage III NSCLC to obtain pCR published this... Read more
29 Jun 2023
•
15mins
Glofitamab & TALAPRO - 2
Glofitamab & TALAPRO - 2
This week's Pod looks at the 2nd CD20-CD3 bispecific T-Cell engager approved this year (or at all), glofitamab, and the ... Read more
22 Jun 2023
•
12mins
ASCO '23 Entrees
ASCO '23 Entrees
We highlight notable data from this month's ASCO annual meeting.1. SONIA: sequence (1st or 2nd-line) CKD 4/6i in MBC2. A... Read more
15 Jun 2023
•
27mins
ASCO '23 Appetizers
ASCO '23 Appetizers
ASCO '23 Appetizers by John Bossaer
8 Jun 2023
•
11mins
PROpel and Cilostazol to Prevent Paclitaxel Neuropathy
PROpel and Cilostazol to Prevent Paclitaxel Neuropathy
Olaparib + Abiraterone is FDA approved for mutated-BRCA prostate cancers. Olaparib has a bit of convoluted story to unp... Read more
1 Jun 2023
•
17mins
Epcoritamab
Epcoritamab
We discuss the newly approved CD20-CD3 T-cell engager for subcutaneous (SC) administration to treat DLBLC after 2 or mor... Read more
25 May 2023
•
15mins